CFDB - Cystic Fibrosis DataBase

Evaluation of the effectiveness of 7% plus hypertonic saline in comparison with 7% hypertonic saline in reducing the growth of Pseudomonas aeruginosa in lung of the patient with cystic fibrosis disease. - Recruiting

ongoing trials  trial from other registries

Details
  • 2021

The effect of compound honey syrup on clinical manifestations of chronic sinusitis in cystic fibrosis (CF) patients - Recruiting

ongoing trials  trial from other registries

Details
  • 2021

A Phase 3b Open-label Study Evaluating the Effects of Elexacaftor/Tezacaftor/Ivacaftor on Cough and Physical Activity in Cystic Fibrosis Subjects 12 Years of Age and Older Who Are Heterozygous for the F508delMutation and a Minimal Function Mutation (F/MF)

ongoing trials  trial from other registries

Details
  • 2021

A randomized, open-label, active controlled, parallel group, multicenter phase 3 study to evaluate the efficacy and tolerability of Bamlanivimab and Etesevimab, Casirivimab and Imdevimab, and Sotrovimab versus Standard of Care in patients with mild to moderate COVID-19 disease (AntiCov)

ongoing trials  trial from other registries

Details
  • 2021

Study to Evaluate Adverse Events and Change in Disease Activity With Oral Capsules of Galicaftor/Navocaftor/ABBV-119 Combination Therapy in Adult Participants With Cystic Fibrosis - Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • AbbVie

GLP-1 Agonist Therapy in Cystic Fibrosis-Related Glucose Intolerance - Phase 2 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2021
  • University of Pennsylvania|Children's Hospital of Philadelphia

A Phase 3b Open-label Study Evaluating the Safety of Elexacaftor/Tezacaftor/Ivacaftor Combination Therapy in Subjects With Cystic Fibrosis

ongoing trials  trial from other registries

Details
  • 2020

Ph 1/2 Study Evaluating Safety and Tolerability of Inhaled AP-PA02 in Subjects With Chronic Pseudomonas Aeruginosa Lung Infections and Cystic Fibrosis - Phase 1|Phase 2 - Recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2020
  • Armata Pharmaceuticals, Inc.|Cystic Fibrosis Foundation

Effect of Postprandial Insulin Administration of Faster-acting Insulin Analogue Versus Pre-prandial Administration of Acting-insulin Analogue in Cystic Fibrosis Related Diabetes - Phase 4 - Not yet recruiting

ongoing trials  trial from www.clinicaltrials.gov

Details
  • 2020
  • University Hospital, Strasbourg, France

A Phase 3b Open-label Study to Assess the Effect of Elexacaftor/Tezacaftor/Ivacaftor on Glucose Tolerance in Cystic Fibrosis Subjects with Abnormal Glucose Metabolism

ongoing trials  trial from other registries

Details
  • 2020